葡萄糖稳态
糖异生
生物
先天性淋巴细胞
内分泌学
内科学
糖原
平衡
转录因子
受体
先天免疫系统
糖尿病
医学
生物化学
新陈代谢
胰岛素抵抗
基因
作者
Masanori Fujimoto,Masataka Yokoyama,Masahiro Kiuchi,Hiroyuki Hosokawa,Akitoshi Nakayama,Naoko Hashimoto,Ikki Sakuma,Hidekazu Nagano,Kazuyuki Yamagata,Fujimi Kudo,Ichiro Manabe,Eunyoung Lee,Ryo Hatano,Atsushi Onodera,Kiyoshi Hirahara,Koutaro Yokote,Takashi Miki,Toshinori Nakayama,Tomoaki Tanaka
标识
DOI:10.1038/s41467-022-33171-6
摘要
Abstract The liver stores glycogen and releases glucose into the blood upon increased energy demand. Group 2 innate lymphoid cells (ILC2) in adipose and pancreatic tissues are known for their involvement in glucose homeostasis, but the metabolic contribution of liver ILC2s has not been studied in detail. Here we show that liver ILC2s are directly involved in the regulation of blood glucose levels. Mechanistically, interleukin (IL)-33 treatment induces IL-13 production in liver ILC2s, while directly suppressing gluconeogenesis in a specific Hnf4a/G6pc-high primary hepatocyte cluster via Stat3. These hepatocytes significantly interact with liver ILC2s via IL-13/IL-13 receptor signaling. The results of transcriptional complex analysis and GATA3-ChIP-seq, ATAC-seq, and scRNA-seq trajectory analyses establish a positive regulatory role for the transcription factor GATA3 in IL-13 production by liver ILC2s, while AP-1 family members are shown to suppress IL-13 release. Thus, we identify a regulatory role and molecular mechanism by which liver ILC2s contribute to glucose homeostasis.
科研通智能强力驱动
Strongly Powered by AbleSci AI